Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-057521
Filing Date
2015-06-30
Accepted
2015-06-30 16:05:26
Documents
2
Period of Report
2015-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1557
2 EX-24 DOCUMENT attachment1.htm EX-24 5012
  Complete submission text file 0001209191-15-057521.txt   8029
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Issuer) CIK: 0001559053 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA BIOSCIENCES INC 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Harfstrand Karl Anders Olof (Reporting) CIK: 0001646451 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35676 | Film No.: 15961479